SCHEMBL2876289

SCHEMBL2876289

COc1cccc(-c2ccc(-c3nc(-c4ccc(-c5cccc(OC)c5)cc4)nc(-c4ccc(-c5cccc(OC)c5)cc4)n3)cc2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XDH P47989 1/20 0.64
▸ CLK4 Q9HAZ1 2/20 0.59
▸ DYRK1A Q13627 1/20 0.59
▸ NPC1 O15118 2/20 0.57
▸ RAB9A P51151 2/20 0.57
▸ TP53 P04637 1/20 0.57
▸ NFKB1 P19838 1/20 0.57
▸ NFKB2 Q00653 1/20 0.57
▸ RELA Q04206 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ ABL1 P00519 2/20 0.56
▸ ABCB1 P08183 2/20 0.56
▸ BCR P11274 2/20 0.56
▸ MAOB P27338 2/20 0.56
▸ CYP1A2 P05177 3/20 0.54
▸ CYP3A4 P08684 3/20 0.54
▸ CYP2C9 P11712 3/20 0.54
▸ CYP2B6 P20813 2/20 0.54
▸ VDR P11473 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23383679 0.96 CLK4 (0.65) XDHCLK4DYRK1ANPC1RAB9A
SCHEMBL29712524 0.89 CYP1A2 (0.67) CLK4DYRK1ANPC1RAB9ATP53
SCHEMBL28315176 0.89 CYP1A2 (0.67) CLK4DYRK1ANPC1RAB9ATP53
SCHEMBL1180343 0.88 ABL1 (0.69) XDHCLK4DYRK1AABL1ABCB1
SCHEMBL6763922 0.84 CLK4 (0.56) XDHCLK4DYRK1ANPC1RAB9A
SCHEMBL13247865 0.84 ABL1 (0.64) XDHCLK4DYRK1ANPC1RAB9A
SCHEMBL1180412 0.84 ABL1 (0.77) XDHCLK4DYRK1AABL1ABCB1
SCHEMBL792197 0.84 ABL1 (0.77) XDHCLK4DYRK1AABL1ABCB1
SCHEMBL196765 0.83 CYP3A4 (0.73) XDHCLK4DYRK1AABL1ABCB1
SCHEMBL29489425 0.83 CYP3A4 (0.73) XDHCLK4DYRK1AABL1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9691991-B2 Organic light emitting diode LG CHEM, LTD. (KR) 2017-06-27 — — US disclosed
US-9691991-B2 Organic light emitting diode LG CHEM, LTD. (KR) 2017-06-27 — — US disclosed
US-20140203272-A1 ORGANIC LIGHT EMITTING DIODE LG CHEM, LTD. (KR) 2014-07-24 — — US disclosed
US-20140203272-A1 ORGANIC LIGHT EMITTING DIODE LG CHEM, LTD. (KR) 2014-07-24 — — US disclosed
US-7777407-B2 Organic light emitting devices comprising a doped triazine electron transport layer LG DISPLAY CO., LTD. (KR) 2010-08-17 — — US disclosed
US-20090102373-A1 Electroluminescent device HAYOZ PASCAL 2009-04-23 — — US disclosed
US-20080199726-A1 Electroluminescent Device CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2008-08-21 — — US disclosed
EP-1743011-A1 ELECTROLUMINESCENT DEVICE CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2007-01-17 — — EP disclosed
US-20060251920-A1 Organic light emitting devices comprising a doped triazine electron transport layer XEROX CORPORATION 2006-11-09 — — US disclosed
US-20060251919-A1 Organic light emitting devices XEROX CORPORATION 2006-11-09 — — US disclosed
EP-1597938-A2 ELECTROLUMINESCENT DEVICE Ciba SC Holding AG (CH) 2005-11-23 — — EP disclosed
WO-2005105950-A1 ELECTROLUMINESCENT DEVICE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-11-10 — — WO disclosed
US-6821643-B1 SATISFACTORY EMISSION IN THE VISIBLE SPECTRUM FROM BLUE TO LONGER WAVELENGTH REGIONS XEROX CORPORATION 2004-11-23 — — US disclosed
WO-2004077885-A2 ELECTROLUMINESCENT DEVICE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-09-10 — — WO disclosed
US-6225467-B1 UNIFORM LUMINESCENCE, ELECTROLUMINESCENT EFFICIENCY, DURABILITY, LOW DRIVING VOLTAGE; FOR USE IN FLAT-PANEL EMISSIVE DISPLAY TECHNOLOGIES, INCLUDING TELEVISION SCREENS, COMPUTER SCREENS XEROX CORPORATION 2001-05-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090102373-A1 Electroluminescent device TAAR5, TYR, TRPC5 XDH 857/4885CLK4 1278/4885DYRK1A 2859/4885
US-20080199726-A1 Electroluminescent Device TPMT, THPO, KYNU XDH 34/4885CLK4 3815/4885DYRK1A 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback